What Is Generic Effective Rate (GER)?
Generic Effective Rate (GER) is a PBM (pharmacy benefit manager) contract metric that measures the average reimbursement rate for generic drug claims, expressed as a percentage discount off Average Wholesale Price (AWP). GER is calculated in aggregate across a defined pool of claims over a set period — not on a per-prescription basis. Importantly, GER encompasses both the drug ingredient cost and the dispensing fee, not just the AWP ingredient discount — a distinction many practitioners miss.
As a practical example: a PBM sets a GER target of AWP minus 85%. If actual aggregate reimbursement across all generic claims averages AWP minus 82% over the quarter, the pharmacy received more than the contracted target and owes a retroactive payment — commonly called a clawback — to the PBM.
How Generic Effective Rate Works
The most commonly misunderstood aspect of GER is that it is evaluated at the aggregate claim-pool level. A pharmacy cannot assess compliance by reviewing individual prescriptions; the measure only materializes at period end.
Step 1: Contract Setup
The PBM specifies a GER target — such as AWP minus 85% — applied across all generic claims for a pharmacy or network over a defined performance period (monthly, quarterly, or annually). The target covers both ingredient cost reimbursement and the dispensing fee, setting the combined floor for average generic reimbursement.
Step 2: Point-of-Sale Reimbursement
Individual prescriptions are reimbursed at per-claim rates, typically MAC-based or AWP-discount-based. The pharmacy receives payment in real time but has no reliable way to know whether aggregate performance is tracking inside or outside the GER target without dedicated monitoring systems.
Step 3: Period-End Reconciliation
The PBM calculates total reimbursed amount divided by total AWP across all generic claims in the pool. If aggregate reimbursement exceeded the GER target, the difference becomes a retroactive charge. A critical ambiguity here: reconciliation may occur at the individual pharmacy, chain, buying-group, or book-of-business level. A pharmacy performing within target on its own claims can still trigger a clawback if network peers underperform and the measurement is applied at the broader pool level — a major source of pharmacy disputes.
Step 4: True-Up
The pharmacy pays a clawback if aggregate reimbursement exceeded the GER target. If reimbursement fell short of the target, the PBM owes the pharmacy a makeup payment. In practice, clawbacks are significantly more common than makeup payments.
GER vs. MAC Pricing
Both GER and MAC (Maximum Allowable Cost) pricing govern generic drug reimbursement in PBM contracts, but they operate at different levels and on different timeframes.
| Dimension | GER | MAC Pricing |
|---|---|---|
| Definition | Aggregate average reimbursement rate across a claim pool | Per-drug reimbursement ceiling set by the PBM |
| Primary purpose | Guarantee average contract performance over a period | Cap ingredient cost on individual generic claims at point of sale |
| How reimbursement is calculated | Total reimbursed ÷ total AWP across all generic claims | Fixed maximum price per drug, applied per transaction |
| When reconciliation occurs | Period end (monthly, quarterly, or annually) | At point of sale, in real time |
| Best used when | Evaluating or guaranteeing aggregate network performance | Enforcing per-drug cost control across dispensing events |
Use GER when evaluating or guaranteeing aggregate reimbursement performance across a claim pool over a contract period. Use MAC pricing when enforcing a per-drug reimbursement ceiling at the point of sale. Notably, the two mechanisms interact: a pharmacy can be fully compliant with per-claim MAC rates and still trigger a GER clawback if aggregate performance diverges from the contracted target.
GER in Pharmacy Benefit and Enterprise Contract Management
GER surfaces in three practical contexts:
- Plan sponsors and employers use GER benchmarks to compare PBM bids, validate contract guarantees, and identify red flags in contract language — such as undefined performance periods or ambiguous measurement-level provisions.
- Pharmacy operators and buying groups monitor aggregate GER compliance to anticipate clawbacks, flag measurement disputes, and negotiate more favorable contract terms at renewal.
- Pricing and contracting teams in any governed commercial environment encounter the same underlying principle: a metric evaluated in aggregate requires aggregate monitoring infrastructure. Per-transaction compliance does not guarantee aggregate compliance — and the gap between the two is where financial exposure accumulates.
Limitations and Strategic Risks
- Retroactive clawback unpredictability. Pharmacies cannot easily track aggregate GER compliance in real time. Cash-flow impacts arrive without warning at period end, complicating revenue forecasting and working capital management.
- Specialty pharmacy margin erosion. High-AWP specialty generics included in GER pools can pull effective aggregate reimbursement below dispensing cost. This is a documented concern for specialty pharmacies whose drug mix differs significantly from a standard retail generics pool.
- Measurement-level ambiguity. When GER is assessed at the buying-group or book-of-business level, a high-performing pharmacy absorbs clawbacks driven by peers' dispensing patterns — not its own. Contract language rarely makes this aggregation level explicit.
- Contract language opacity. GER targets, performance periods, and true-up formulas are not consistently defined with precision. Without clear audit rights, independent verification of PBM calculations is difficult, limiting a pharmacy's ability to dispute a clawback effectively.
Related Terms: Brand Effective Rate (BER) | Average Wholesale Price (AWP) | Maximum Allowable Cost (MAC) | Dispensing Fee Effective Rate (DFER) | DIR Fees
